GILD (GILD) Stock Price & Analysis
GILD (GILD) fell 0.15% to USD 151 as of September 8, 2026 at 02:53 UTC, according to Nexqual real-time market data.
GILD last closed at USD 151; the session ranged USD 149.23–151.19 on volume of 6,181,783 shares. Market capitalization is —, with a 52-week range of USD 108.46–157.29 (NMS). Source: Nexqual, September 8, 2026 at 02:53 UTC.
Key Statistics (as of September 8, 2026 at 02:53 UTC)
| Price | USD 151 |
|---|---|
| Change | ▼ 0.15% (down) |
| Previous Close | USD 151 |
| Open | USD 151 |
| Day Range | USD 149.23 – 151.19 |
| 52-Week Range | USD 108.46 – 157.29 |
| Volume | 6,181,783 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (GILD)
Nexqual's technical model rates GILD "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 02:53 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 68.81 (neutral) |
| vs SMA50 | Above (USD 136.6) |
| MACD | 4.33 (positive) |
From GILD's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMGN | Amgen Inc. | USD 437.23 | ▼ 1.27% |
| BIIB | Biogen Inc. | USD 220.83 | ▼ 0.83% |
| ABBV | AbbVie Inc. | USD 256.46 | ▼ 2.01% |
| BMY | Bristol-Myers Squibb Company | USD 66.82 | ▼ 1.24% |
| REGN | Regeneron Pharmaceuticals, Inc. | USD 827.72 | ▼ 2.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 02:53 UTC. This page is informational and not investment advice.